Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.445 AUD | 0.00% | -1.11% | -21.93% |
05-15 | Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call | |
05-09 | Imricor Medical Systems' VISABL-AFL Trial Receives Final Clearance from Swissmedic | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.93% | 59.8M | |
+9.79% | 223B | |
+13.32% | 194B | |
+20.29% | 141B | |
+31.17% | 109B | |
+2.05% | 64.85B | |
+15.36% | 52.7B | |
+3.96% | 51.77B | |
+7.77% | 44.12B | |
+3.36% | 36.21B |
- Stock Market
- Equities
- IMR Stock
- News Imricor Medical Systems, Inc.
- Imricor Medical Systems Gains Approval for Clinical Trial at Cardiovascular Institute of South Paris; Shares Up 7%